Ebola clinical trial expands to Congo’s outbreak hot spots

An ongoing clinical trial of four experimental Ebola treatments will start to enroll participants at two outbreak hot spots in the Democratic Republic of Congo, Doctors Without Borders announced Feb. 12.

Advertisement

Three things to know:

1. The clinical trial, launched in November, seeks to identify the most effective Ebola treatment of four experimental therapies: Remdesivir, mAb114, REGN-EB3 and ZMapp.

2. The trial will now involve Ebola patients in treatment centers in Katwa and Butembo — current hot spots of Congo’s Ebola outbreak.

3. As of Feb. 11, the World Health Organization reported 819 confirmed and probable infections linked to the outbreak, which started in August.

More articles on clinical leadership & infection control:
Why combining nurse perspective with scientific approach improves care
Health experts urge Facebook to crack down on anti-vaccine groups
Former CDC leader on bird flu threat: ‘We don’t know how the story’s going to end’

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.